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压 CO2 和 N2 中的熔点。结果表明：在超临界 CO2 中，布洛芬和肉豆蔻酸的熔点
均随体系压力的增大而迅速降低，分别由各自常压熔点降低至 45 °C 和 36 °C 左
右，在体系压力达到 10MPa 后基本保持不变；在超临界 N2 中，布洛芬和肉豆蔻
酸的熔点随着压力的增大保持不变或略有增大，基本稳定在各自常压熔点。用
PR-NRTL 模型和 GE-EOS 模型对布洛芬和肉豆蔻酸在高压气体中的气液固三相
平衡进行计算和预测。结果表明，通过调节 NRTL 模型参数，PR-NRTL 模型可
以获得与实验结果相吻合的结果：在高压 CO2和 N2中布洛芬熔点计算值与实验
结果的平均绝对误差分别为 1.6K 和 0.099K；在高压 CO2 和 N2 中肉豆蔻酸熔点
计算值与实验结果的平均绝对误差分别为 1.1K 和 0.074K。GE-EOS 模型结合




























根据对纯药物和脂的微粒化结果，用 PGSS 实验装置以超临界 CO2 或 N2 对




度研究表明，无论是 CO2 还是 N2 制备的布洛芬/肉豆蔻酸微胶囊均没有对布洛芬
起到缓释效果。将肉豆蔻酸改变为三棕榈酸甘油酯进行布洛芬的微胶囊化研究，
结果表明，含 5%或 20%药物的布洛芬/三棕榈酸甘油酯微胶囊能明显对布洛芬起



















Using supercritical fluids (SCFs) to manufacture microparticles/microspheres is a 
promising direction in chemical engineering, material science, pharmaceutical, and so 
on. SCF technology has some significant advantages over traditional methods, such as 
little environmental pollution, preferable particle morphology (PM), controllable 
particle sizes, and simple equipments. In order to obtain desired particles with small 
particle size (PS) and narrow particle size distribution (PSD), and/or microspheres 
with controlled release, several SCF-based techniques have been proposed in the past 
decades, among them, the particle formation from gas-saturated solutions (PGSS) 
process attracted great interest of lots of investigators due to several unique features. 
The studies of this thesis include two parts: study on solid-liquid-gas (SLG) phase 
equilibrium and generation of microparticles/microspheres by using PGSS. In the first 
part, an apparatus was established, the melting points of myristic acid and ibuprofen 
under high pressures of CO2 and N2 were measured, and the SLG phase equilibrium 
was theoretically investigated. In the second part, a PGSS experimental apparatus was 
improved, and the generation of ibuprofen and myristic acid microparticles and 
ibuprofen/lipid microspheres was investigated by using both CO2 and N2. 
 A high-pressure apparatus with a view cell for determining the melting points of 
ibuprofen and myristic acid in CO2 and N2 was built; the capillary method was used. 
The measured data indicated that the melting points of myristic acid and ibuprofen 
decreased to 45°C and 36°C, respectively, with the increase of the CO2 pressure; they 
kept almost unchanged after 10MPa. The melting points of the two substances had no 
change or slightly increased with the increase of the N2 pressure. The SLG phase 
equilibrium for the ibuprofen-CO2, myristic acid-CO2, ibuprofen-N2, myristic acid-N2 














model showed a good correlation with the experimental results through adjusting the 
NRTL-model parameters: the absolute average deviations (ADDs) between the 
correlated and experimental melting points of ibuprofen or myristic acid were 1.6K, 
0.099K, 1.1K and 0.074K, respectively, for the ibuprofen-CO2, ibuprofen-N2, myristic 
acid-CO2, and myristic acid-N2 systems. The predictions of the GE-EOS model with 
the LCVM mixing rules showed a good agreement with the experimental data: ADDs 
were 1.2K and 0.88 K, respectively, for the ibuprofen-CO2 and myristic acid-CO2 
systems. A different ADD (2.7K) was obtained for the latter system when using the 
other set of critical constants of myristic acid, indicating the sensitivity of the physical 
property to the SLG phase behavior.  
A PGSS apparatus was improved for using both CO2 and N2. Based on the SLG 
investigations, the particle generation of ibuprofen by using CO2 revealed that 
needle-like particles or plates were produced in high-pressure region, while spherical 
particles could be found at relatively low pre-expansion pressures. The obtained SEM 
pictures showed that the average PS of processed particle was between 2 and 3μm. In 
the investigated ranges, it was found that a high pre-expansion pressure, a small 
nozzle diameter, or a low pre-expansion temperature favored producing small 
ibuprofen particles. When it comes to the myristic acid particles by using both CO2 
and N2, spherical, needle-like and plate particles were obtained from the CO2-assisted 
process, while hollow, spherical and relatively large particles were obtained in the 
case of using N2. The average PS for particles from the CO2-assisted and the 
N2-assisted processes were 0.8-1.5μm and 5-8μm, respectively. The PS obviously 
decreased and the PSD became narrow when the pre-expansion pressure was 
increased; however, the pre-expansion temperature and the nozzle size showed no 
evident effect on the PS and PSD. Furthermore, the particle formation mechanism was 














particles.   
Based on the conditions and particles generated for pure ibuprofen and myristic 
acid, the ibuprofen/lipid microspheres were investigated by using both CO2-assisted 
and N2-assisted PGSS processes. The obtained microspheres containing 5% or 20% 
ibuprofen showed similar PM, PS and PSD of the myristic acid particles in the case of 
N2-assisted process. Nevertheless, the microspheres from the CO2-assisted process 
had a large PS and broad PSD, compared to that of the pure myristic acid particles. 
Although the XRD analysis of microspheres indicated that ibuprofen was successfully 
encapsuled by myrisitc acid, the ibuprofen dissolution rates from the produced 
microspheres revealed that either the microspheres from the N2-assisted process or 
that from the CO2-assisted process had attained no controlled release for ibuprofen. 
Tripalmitin in place of myristic acid was investigated; the obtained 
ibuprofen/tripalmitin microspheres containing 5% or 20% ibuprofen showed an 
evidently controlled drug release. For example, the drug release was only 20% in 500 
min for the ibuprofen/tripalmitin microspheres containing 20% ibuprofen, prepared by 
the CO2-assisted process. 
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二氧化碳 CO2 31.1 73.8 0.460 
水 H2O 374.3 221.1 0.326 
乙烷 C2H6 32.3 48.8 0.203 
乙烯 C2H4 9.9 51.2 0.227 






















(常温、常压) Tc, Pc ～Tc, 4Pc 
液体 
(常温、常压) 
密度/(g/cm3) 0.0006～0.002 0.2～0.5 0.4～0.9 0.6～1.6 
粘度/(mPa.s) 0.01～0.03 0.01～0.03 0.03～0.09 0.2～3.0 
扩散系数
/(cm3/s) 









































































































且有应用前景的主要有三种：超临界溶液快速膨胀 (Rapid Expansion of 
Supercritical Solutions, RESS)，超临界反溶剂(Supercritical Anti-Solvent, SAS)和气
体饱和溶液微粒形成技术（Particles from Gas-Saturated Solutions，PGSS）。为方
便本文研究的讨论，下面分别介绍 RESS 和 SAS 技术原理、方法及应用， PGSS
技术另外分节重点介绍。 
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